Eupraxia Pharmaceuticals ... (EPRX)

AI Score

Unlock

3.85

0.37 (10.63%)

At close: Apr 22, 2025, 3:59 PM

Eupraxia Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q4 2019
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Dec 31, 2019
Cash & Equivalents	33.1M	8.66M	23.32M	48.59M	19.34M	33.21M	19.1M	18.85M	24.74M	11.8M	17.39M	16.88M	20.89M	33.67M	36.08M	31.12M	150.13K	429.08K	1.16M
Short-Term Investments	n/a	n/a	8.59M	n/a	n/a	n/a	n/a	n/a	n/a	18.17M	18.06M	9.02M	9.01M	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	80.76K	18.43K	6.3K	7.54K	6.9K	4.21K	5.84K	2.84K	3.37K	672.00	854.00	1.03K	31.37K	60.3K	n/a	n/a	n/a	n/a	n/a
Receivables	228.87K	n/a	155.24K	167.24K	190.61K	67.84K	n/a	117.95K	n/a	285.62K	n/a	350.15K	337.03K	n/a	n/a	n/a	486.69K	15.08K	1.03M
Inventory	n/a	n/a	n/a	2.00	-340.53K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	n/a	n/a	n/a	n/a	n/a	n/a	570.47K	250.4K	n/a	417.25K	563.43K	n/a	270.99K	n/a	n/a	666.42K	367.52K	n/a	134.48K
Total Current Assets	34.44M	9.89M	33.56M	49.01M	19.8M	33.77M	19.73M	19.22M	25.18M	30.78M	36.4M	26.64M	30.6M	34.24M	36.86M	32.26M	1.14M	583.13K	2.64M
Property-Plant & Equipment	424.92K	456.49K	609.63K	561.4K	456.25K	573.77K	610.92K	657.57K	695.48K	665.38K	664.5K	556.48K	589.07K	612.41K	279.92K	298.9K	315.34K	337.52K	646.21K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	505.68K	474.92K	615.93K	568.94K	463.15K	577.98K	616.77K	660.41K	698.85K	666.06K	665.36K	557.51K	620.44K	672.71K	279.92K	298.9K	315.34K	337.52K	646.21K
Total Assets	34.94M	10.36M	34.17M	49.58M	20.27M	34.35M	20.35M	19.88M	25.88M	31.45M	37.06M	27.2M	31.22M	34.91M	37.14M	32.56M	1.45M	920.65K	3.29M
Account Payables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	4.55M	12.93M	10.4M	15.33M	11M	179.47K	79.42K	78.42K	163.41K	76.03K	74.44K	73.68K	n/a	6.12M	12.52M	12.37M	11.63M
Other Current Liabilities	1.49M	n/a	4.27M	3.68M	858.63K	1.04M	3.25M	2M	1.6M	1.85M	3.35M	1.06M	1.4M	2.71M	710.77K	320.14K	4.93M	4.26M	4.87M
Total Current Liabilities	3.1M	2.37M	15.88M	25.07M	19.37M	19.28M	14.6M	2.18M	4.14M	2.25M	3.59M	1.26M	2.27M	2.85M	816.35K	7.66M	22.54M	22.1M	20.67M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	28.08K	10.59M	11.99M	10.12M	9.76M	9.62M	9.84M	9.08M	8.78M	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-1.67M	-86.55K	n/a	-96.67K	-542.97K	32.05K	-168.72K	38.17K	419.18K	438.34K	498.15K
Total Long-Term Liabilities	n/a	14.3K	34.95K	n/a	n/a	11.79K	59.1K	10.64M	10.37M	10.12M	9.86M	9.62M	9.4M	9.23M	8.78M	183.69K	574.97K	650.14K	749.35K
Total Liabilities	3.1M	2.39M	15.92M	25.07M	19.37M	19.29M	14.66M	12.82M	14.51M	12.37M	13.45M	10.88M	11.67M	12.07M	9.6M	7.84M	23.12M	22.75M	21.42M
Total Debt	71.86K	93.05K	4.66M	12.93M	10.45M	15.41M	11.13M	10.82M	10.55M	10.29M	10.02M	9.77M	9.56M	9.38M	8.84M	6.36M	12.77M	12.64M	11.94M
Common Stock	116.36M	116.32M	116.32M	157.41M	92.91M	118.05M	99.37M	92.69M	92.34M	91.87M	91.87M	80.71M	80.71M	80.76M	80.76M	74.15M	23.8M	23.55M	23.55M
Retained Earnings	-131M	-123.49M	-117.55M	-150.95M	-108.21M	-122.7M	-110.23M	-102.41M	-97.45M	-88.62M	-83.97M	-77.88M	-74.19M	-70.47M	-65.49M	-60.06M	-51.2M	-51.06M	-47.2M
Comprehensive Income	-4.16M	-2.79M	-2.92M	-3.71M	-2.71M	n/a	n/a	-1.35	-2.79M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	33.4M	9.52M	14.83M	26.45M	2.22M	17.04M	7.44M	8.63M	12.86M	20.31M	24.7M	17.22M	20.39M	23.61M	28.16M	25.17M	-21.21M	-21.38M	-17.69M
Total Investments	n/a	n/a	8.59M	n/a	n/a	n/a	n/a	n/a	n/a	18.17M	18.06M	9.02M	9.01M	n/a	n/a	n/a	n/a	n/a	n/a